SEC Form 4 · accession 0001209191-16-109217
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Derek T Chalmers
Officer — President & CEO · Director
Period of report
Mar 15, 2016
Accepted (ET)
Mar 17, 2016 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 15, 2016 | M | 10,000 | $2.48 | A | 1,097,292 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.48 | Mar 15, 2016 | M | 10,000 | D | — | Nov 7, 2017 | Common Stock | 10,000 | 30,000 | D |
Explanation of responses
- F1Immediately exercisable.